Neonatal Onset of Autosomal Recessive Polycystic Kidney Disease Mimicking Bartter Syndrome: A Case Report
Keywords:
N\AAbstract
Autosomal recessive polycystic kidney disease is an uncommon genetic disorder characterized by cystic enlargement of the renal collecting ducts along with varying degrees of congenital hepatic fibrosis. Neonatal presentation can mimic other tubulopathies like Bartter syndrome due to overlapping biochemical abnormalities. We present a case of a late preterm male neonate, born to consanguineous parents, who exhibited lethargy, dehydration, and significant weight loss by day 8 of life. Clinical evaluation and investigations revealed features of salt-wasting tubulopathy with metabolic alkalosis. Imaging showed enlarged, cystic kidneys, and genetic testing confirmed a homozygous mutation in the PKHD1 gene, consistent with ARPKD. Supportive therapy, including fluid and electrolyte correction and indomethacin, led to clinical improvement. This case underlines the importance of considering ARPKD in neonates with electrolyte imbalance and renomegaly and demonstrates the diagnostic utility of early genetic analysis.
Downloads
Metrics
References
Bergmann C. Early and severe polycystic kidney disease and related Ciliopathies: an emerging field of interest. Nephron. 2019;141(1):50–60.
Arbeiter A, Büscher R, Bonzel KE, Wingen AM, Vester U, Wohlschläger J, Zerres K, Nürnberger J, Bergmann C, Hoyer PF. Nephrectomy in an autosomal recessive polycystic kidney disease (ARPKD) patient with rapid kidney enlargement and increased expression of EGFR. Nephrol Dial Transplant. 2008;23(9):3026–3029.
Mallett TM, O'Hagan E, McKeever KG. Early Bilateral Nephrectomy in Infantile Autosomal Recessive Polycystic Kidney Disease. BMJ Case Rep. 2015;2015:bcr2015211106.
Abbiss H, Maker GL, Trengove RD. Metabolomics approaches for the diagnosis and understanding of kidney diseases. Metabolites. 2019;9(2):34.
Iorio P, Heidet L, Rutten C, Garcelon N, Audrézet MP, Morinière V, Boddaert N, Salomon R, Berteloot L. The "salt and pepper" pattern on renal ultrasound in a Group of Children with Molecular-Proven Diagnosis of Ciliopathy-related renal diseases. Pediatr Nephrol. 2020;35(6):1033–1040.
Melchionda S, Palladino T, Castellana S, Giordano M, Benetti E, De Bonis P, Zelante L, Bisceglia L. Expanding the mutation Spectrum in 130 Probands with ARPKD: identification of 62 novel PKHD1 mutations by sanger sequencing and MLPA analysis. J Hum Genet. 2016;61(9):811–821.
Obeidova L, Seeman T, Elisakova V, Reiterova J, Puchmajerova A, Stekrova J. Molecular genetic analysis of PKHD1 by next-generation sequencing in Czech families with autosomal recessive polycystic kidney disease. BMC Med Genet. 2015;16:116.
Bergmann C, Senderek J, Windelen E, Küpper F, Middeldorf I, Schneider F, Dornia C, Rudnik-Schöneborn S, Konrad M, Schmitt CP, Seeman T, Neuhaus TJ, Vester U, Kirfel J, Büttner R, Zerres K. APN (Arbeitsgemeinschaft für Pädiatrische Nephrologie). Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD) Kidney Int. 2005;67(3):829–848.
Prelog M, Bergmann C, Ausserlechner MJ, Fischer H, Margreiter R, Gassner I, Brunner A, Jungraithmayr TC, Zerres K, Sergi C, Zimmerhackl LB. Successful transplantation in a child with rapid progression of autosomal recessive polycystic kidney disease associated with a novel mutation. Pediatr Transplant. 2006;10(3):362–366.
Bergmann C, Küpper F, Schmitt CP, Vester U, Neuhaus TJ, Senderek J, Zerres K. Multi-exon deletions of the PKHD1 gene cause autosomal recessive polycystic kidney disease (ARPKD) J Med Genet. 2005;42(10):e63.
Bergmann C. ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and Phenocopies. Pediatr Nephrol. 2015;30(1):15–30.
Erger F, Ortiz-Brüchle N, Gembruch U, Zerres K. Prenatal ultrasound, genotype, and outcome in a large cohort of prenatally affected patients with autosomal-recessive polycystic kidney disease and other hereditary cystic kidney diseases. Arch Gynecol Obstet. 2017;295(4):897–906.
Luo F, Gu WZ, Chen Z, Shi LP, Ma XL, Lin HJ, Qiu YH. Infantile polycystic kidney disease: a case report and literature review. Zhonghua Er Ke Za Zhi. 2013;51(5):377–381.
Khare A, Krishnappa V, Kumar D, Raina R. Neonatal renal cystic diseases. J Matern Fetal Neonatal Med. 2018;31(21):2923–2929.
Fischer DM, Jacoby U, Pape L, Ward CJ, Kuwertz-Broeking E, Renken C, Nizze H, Querfeld U, Rudolph B, Mueller-Wiefel DE, Bergmann C, Haffner D. Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD) Nephrol Dial Transplant. 2009;24(6):1819–1827.
Riechardt S, Koch M, Oh J, Fisch M. Early bilateral nephrectomy in neonatal autosomal recessive polycystic kidney disease: improved prognosis or unnecessary effort? Urologe A. 2017;56(7):882–886.
23.Hou L, Du Y, Zhang M, Su P, Zhao C, Wu Y. Novel mutations of PKHD1 and AHI1 identified in two families with cystic renal disease. Int J Clin Exp Pathol. 2018;11(5):2869–2874.
26.Nowak KL, Edelstein CL. Apoptosis and autophagy in polycystic kidney disease (PKD) Cell Signal. 2020;68:109518. doi: 10.1016/j.cellsig.2019.109518.
Walsh SB, Unwin E, Vargas-Poussou R, Houillier P, Unwin R, . Does hypokalemia cause nephropathy?An observational study of renal function in patients with Bartter or Gitelmann syndrome. QJM. 2011;104:939-44.
Peters M, Ermert S, Jeck N, Derst C, Pechmann U, Weber S, . Classification and rescue of ROMK mutations underlying hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int. 2003;64:923-32.
..
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.